Search
Virax executive chairman Wayne Millen.

Virax raises $3m for Pathway takeover

Virax Holdings has completed a $3 million equity placement to sophisticated investors to support its acquisition last week of Pathway Oncology.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

BNIQ sponsored byBreast Cancer Research Centre

Corporate finance employees

5th↑BDO22
6th↑Argonaut16
7th↑Patersons SecuritiesNFP
8th↑Hartleys11
9th-Regency CorporateNFP
81 corporate finance ranked by staff in corporate finance area (WA)

Revenue

57th↓Gemmill HomesNFP
58th-Ross North Group$73.7m
59th↑Patersons Securities$73.4m
60th↓MG Kailis Group$69.9m
61st↓OrontideNFP
113 private companies - large ranked by revenue most recent financial year

Client advisers

1st-Patersons SecuritiesNFP
2nd-Hartleys50
3rd-Euroz Securities37
4th-Bell Potter Securities31
5th↑Macquarie Group29
20 stockbrokers ranked by number of client advisers in WA

Number of Employees

Corporate Finance

BNiQ Disclaimer